Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study :

✍ Scribed by Banerjee, A.; Lane, D. A.; Torp-Pedersen, C.; Lip, G. Y. H.

• Book ID: 111943594
• Publisher: Schattauer
• Year: 2012
• Tongue: English
• Weight: 159 KB
• Volume: 107
• Category: Article
• ISSN: 0340-6245
• DOI: 10.1160/th11-11-0784